Cargando…
Challenges in using (18) F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer
BACKGROUND: The best method of identifying regions within pancreatic tumours that might benefit from an increased radiotherapy dose is not known. We investigated the utility of pre-treatment FDG-PET in predicting the spatial distribution of residual metabolic activity following chemoradiotherapy (CR...
Autores principales: | Wilson, James M, Mukherjee, Somnath, Chu, Kwun-Ye, Brunner, Thomas B, Partridge, Mike, Hawkins, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078370/ https://www.ncbi.nlm.nih.gov/pubmed/24962658 http://dx.doi.org/10.1186/1748-717X-9-146 |
Ejemplares similares
-
The value of [(18)F]fluorodeoxyglucose-PET/CT in oesophageal cancer
por: Rankin, S.
Publicado: (2011) -
Correlation of (18)F-Fluorodeoxyglucose Positron Emission Tomography Parameters with Patterns of Disease Progression in Locally Advanced Pancreatic Cancer after Definitive Chemoradiotherapy
por: Wilson, J.M., et al.
Publicado: (2017) -
Inflammatory Pseudotumor in the Mediastinum: Imaging with (18)F-Fluorodeoxyglucose PET/CT
por: Yoon, Seok-Ho, et al.
Publicado: (2013) -
Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
por: Holyoake, Daniel L.P., et al.
Publicado: (2017) -
(18)F-Fluorodeoxyglucose PET/CT in a Patient with Esophageal and Genital Leiomyomatosis
por: An, Young-Sil, et al.
Publicado: (2009)